MPM BioVentures 2014, L.P. 13D/13G Filings for Harpoon Therapeutics, Inc. (HARP)

MPM BioVentures 2014, L.P. 13D and 13G filings for Harpoon Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-12
4:09 pm
Purchase
2024-02-1213DHarpoon Therapeutics, Inc.
HARP
MPM BioVentures 2014, L.P. 663,806
3.700%
663,806increase
(New Position)
Filing